What is Tesamorelin?
Tesamorelin is a stabilized GHRH analog that is FDA-approved to reduce excess visceral (abdominal) fat in people with HIV-associated lipodystrophy. It has also been studied for cognitive and metabolic outcomes.
Also known as: TH9507
How Tesamorelin is studied
Tesamorelin is a stabilized GHRH analog that boosts the body's growth-hormone axis. Unlike most research peptides, it is FDA-approved for a specific indication — reducing excess visceral (abdominal) fat in people with HIV-associated lipodystrophy — and has also been studied for cognitive and metabolic outcomes.
Commonly researched for
Typically stacked with
Research status
Important considerations
Prescription medication for its approved use. Affects growth hormone axis.
Tesamorelin — frequently asked questions
It is FDA-approved to reduce excess visceral abdominal fat in people with HIV-associated lipodystrophy. Other uses are off-label or investigational.
Its approved evidence is specific to HIV-associated visceral fat. Broader use is not established and it affects the growth-hormone axis.
Yes, for its approved use. It should only be used under medical supervision.